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Abstract. Polycystic ovary syndrome (PCOS) is one of the most common 
endocrine disorders in women. The clinical manifestation of PCOS varies from a 
mild menstrual disorder to severe disturbance of reproductive and metabolic 
functions with severe long-term health consequences. High-frequency of 
endocrine-metabolic disorder’s and anovulatory infertility and also frequent 
absence of effect from the use of traditional charts of medicament induction of 
ovulation resulted in the search of alternative ways of proceeding in fecundity. 
The aim of this study was to evaluate the clinical efficiency of different 
treatments cancellation and infertility in women with PCOS and 
hyperprolactinemia. Materials and methods. We performed retrospective 
analysis of 502 consecutive case histories during 5 years of reproductive results 
of treatment of women is with anovulatory infertility, caused by different 
factors. Aim of the study was to determine the efficiency of conservative and 
surgical treatment. Results. Differentiated application of conservative medical 
therapy allows to attain the effect of proceeding in a fertile function in 33, 8% of 
patients. It is found that surgical induction of ovulation by ovarian laparoscopic 
partial degradation is an option in the management of female infertility 
associated with PCOS, especially as a second-line treatment after the failure of 
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clomiphene citrate treatment, enhancing the efficiency of complex infertility 
treatment to 40%. It is feasible to develop an algorithm differentiated use of 
infertility treatments in women with PCOS and hyperprolactinemia. 
Keywords: Polycystic ovary syndrome (PCOS); reproductive health; 
hyperandrogenism; infertility; hyperprolactinemia; hirsutism; menstruation 
disorders.  
Introduction. Demographic potential of Ukrainian population is 
burdened with considerable extension of female infertility [1]. According to 
local scientists fertility rate in excess of 10% can be considered as direct 
reproductive losses that significantly impair the demographic situation of the 
country. Many of Ukrainian females have anovulatory infertility. It has a 
tendency to spread in the population, with involvement in the pathogenesis of 
disorders of ovulation excess synthesis of androgens and prolactin. 
Polycystic ovary syndrome (PCOS) is the most common endocrine 
disorder in women. The clinical manifestation of PCOS varies from a mild 
menstrual disorder to severe disturbance of reproductive and metabolic 
functions [3-5]. Significant progress achieved domestic and foreign scholars and 
the development of surgical induction of ovulation in PCOS [6, 7]. 
However, the results of treatment of anovulatory infertility associated 
with PCOS, indicating that the disease is distinguished not only clinical 
polymorphism, but also has several pathogenic variants. It is possible that this 
group of patients, along with there are other endocrine disorders that also affect 
metabolic processes. Thus, the high incidence of hyperprolactinaemia was found 
among patients with PCOS deepens dysmetabolic changes in the patient, 
involving additional mechanisms in the pathogenesis of blocking ovulation [8-
10]. This can be explained as the influence of prolactin receptors on ovarian 
stimulation and compression as β- cells of the pancreas, leading to the 
development of insulin resistance. So important is the optimization approaches 
to the treatment of patients with PCOS with regard to the likely role of 
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hyperprolactinemia. However, to date research on the comparative evaluation of 
clinical effectiveness (efficiency) of different methods of multivariate stimulate 
ovulation in anovulatory infertility, occur less frequently. 
The aim was to evaluate the clinical efficiency of different treatments 
cancellation and infertility in women with PCOS and hyperprolactinemia. 
Materials and methods. The survey was conducted at the department of 
invasive methods and diagnostics of university clinic of Odessa National 
Medical University (Odessa) and multi-field medical center" Avicenna 
"(Melitopol). The conducted retrospective analysis of reproductive results of 
treatment of women is with multivariable anovulatory infertility. Retrospective 
search depth was 5 years.  A total analysis includes 502 case histories 
During the study of data of medical documentation we paid attention to the 
next features.  PCOS Diagnosed in agreement with criteria of Rotterdam 
consensus sponsored in part by the European Society for Human Reproduction 
and Embryology and the American Society for Reproductive Medicine (2003), 
based on the presence of chronic oligo- or anovulation, clinical and/or 
biochemical signs of hyperandrogenism, or polycystic ovaries on ultrasound 
examination [11]. Patients with hyperprolactinemia were conducted double 
determination of prolactin in serum by enzyme-linked immunosorbent assay 
(ELISA)to exclude tumours and pituitary hypothalamic syndromes X-ray and/or 
MRI of the brain were performed. 
In the course of further analysis on the retrospective phase of the study 
were identified six groups of patients, depending on the efficiency of 
conservative or used surgical treatments. 
The first group consisted of 21 (10.7 %) women with an initial phase of 
the hypothalamic-pituitary dysfunction with menstrual disorders and genital 
infantilism, which became pregnant due to the correction of hormonal relations 
by therapy on the type of rebound - effect. 
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Another group included 27 (13.8 %) women with PCOS who become 
pregnant during treatment with standard ovulation stimulation by the 
medications include clomiphene citrate (a selective estrogen receptor 
modulator). One woman had born twins, however one patient (twice) had 
ectopic pregnancy. 
The third group involved of 23 (11.7 %) women with PCOS and adrenal 
hyperandrogenism, without severe symptoms of hyperprolactinemia who 
became pregnant by the treatment of derivatives of the corticosteroid hormones 
cortisol and aldosterone that are produced naturally by the adrenal glands 
(Dexamethasone). All pregnancies resulted in deliveries in time without 
conclusions. 
The fourth group was composed of 25 (12.8%) patients with PCOS in 
combination with adrenal hyperandrogenism and symptoms of 
hyperprolactinemia. They were treated with Dexamethasone and a dopamine 
agonist ergoline derivative - Bromocriptine, is an in communicating from a 
minimum dose to maximal or effective (optimize). In all cases, the patient 
became pregnant within six months of beginning treatment after the renewal of 
ovulation. 
The fifth group contained of 18 (9.2%) women who became pregnant in 
the ordinary cycle after surgical induction of ovulation by laparoscopic partial 
ovarian destruction (that was directed at inefficiency by applications of medicine 
correction).  
Determinations of authenticity of differences between the compared 
groups or subgroups on frequencies of separate clinical indexes or outputs 
performed by using 2  test with Yates correction given for paired comparisons 
and Bonferoni correction for multiple comparisons to the control group. 
Statistical study was performed using the programmatic complex Statistica 10.0 
(StatSoft Inc., USA) [12]. 
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The results. From the general amount of patients with anovulatory 
infertility (502 persons) 196 women are selected with verification of PCOS in 
combined with symptoms of hyperprolactinemia.  
In results of research a variant of multifactor anovulatory sterility of met 
in 39. 0 % of cases, this version exceed the values led by different studies that 
have been described by other researchers. In assessing the hormonal profile of 
patients showed that the levels of prolactin are higher than the reference value 
and averaged 18.8 ± 1.1 ng / ml (Table 1). 
According to the data of table, the results of hormonal profile of inspected 
women indicate a variability of damages of women with PCOS and 
hyperprolactinemia, and PCOS and hyperandrogenism. Patients had increased 
fraction of LH / FSH to 2.1 ± 0.1 by increasing LH content (up to 13.2 ± 0.5 IU / 
l) and decrease in FSH (to (6.5±0.2) mIU/l), hyperandrogenism - 
androstenedione level - 4.2±0.2 nmol/l, testosterone -2.8±0.2 nmol/l, DHEA -S - 
4.0±0.3 nmol/l), progesterone (8.0 ± 0.5 nmol/l) on a background of moderate 
hypoestrogenic state (45.0 ± 2.2 pg / ml). Representative for all patients where 
normal levels of AMH (2.7 ± 0.2 ng / ml), indicating a high ovarian reserve. 
Request of surgical induction after the previous course of hormonotherapy 
in 82 (41.8%) of women with sterility was not effective. These women were 
guided to assisted reproductive technology clinic. 
As established in Table 1 the patients of different groups did not differ on 
age, middle age in groups had laid down 27.8±0.7. The investigation of 
complaints of patients found that and menstrual disorders prevailed among other 
conditions, and infertility duration on the average laid down 5.6±0.4 years. In 
further study the presence of statistically significant differences by the hirsute 
number, free testosterone index in patients with III and IV groups. Relatively 
low levels of prolactin (6.9 ± 0.5 ng/ml) were observed in patients with a 
preliminary phase of the hypothalamic-pituitary dysfunction.  
Table 1 
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Clinical physiognomies of patients 
Indices І group 
(n=21) 
ІІ group 
(n=27) 
ІІІ group 
(n=23) 
IV group 
(n=25) 
V group 
(n=18) 
Age, year 27.0±0.4 30.0±0.5 30.1±0.4 26.2±0.3 30.0±0.4 
BMI, kg/m² 22.3±0.4 24.9±0.4 24.6±0.3 20.3±0.4 22.3±0.4 
Hirsute number, scores 6.9±0.1 8.7±0.4 9.9±0.2* 7.3±0.2 8.9±0.1* 
FSH, mIU/l 9.8±1.5 4.2±0.2 7.1±0.4 11.3±0.3 9.8±1.5 
LH, mIU/l 11.8±1.3 12.1±0.3 10.0±0.6 14.0±0.4 14.8±1.3 
LH/FSH 1.2±0.3 3.3±0.5 1.7±0.2 1.4±0.1 1.2±0.3 
Estradiol, pmol/l 68.2±5.6 45.0±2.2 50.1±7.0 57.9±4.5 68.2±5.6 
Progesterone, nmol/l  1.6±0.1 1.2±0.2 2.0±0.2 1.9±0.2 1.6±0.1 
17-ОН progesterone, 
nmol/l 
1.2±0.2 0.8±0.5 1.9±0.2 1.1±0.1 1.2±0.2 
DHEAS, mcmol/l 3.4±0.3 4.0±0.3 4.9±0.2 4.8±0.3 4.4±0.3 
Prolactin, ng/ml  6.9±0.5 11.3±0.4 16.4±0.5 34.2±1.2
* 
16.9±0.5 
TTH, mMI/l 1.8±0.2 1.9±0.2 2.6±0.2* 1.5±0.3 2.8±0.2* 
Т4, pmol/l 4.2±0.2 4.0±0.3 4.4±0.3 4.3±0.2 4.2±0.2 
Androstenedione, 
nmol/l 
4.2±0.2 4.0±0.2 4.8±0.4 3.8±0.2 4.2±0.2 
AMH, ng/ml 2.7±0.2 3.1±0.3 3.0±0.3 2.4±0.3 2.7±0.2 
 
The highest levels of 17 -OH progesterone (1.9 ± 0.2 nmol/l) were 
observed in patients of group III. However, the content of DHEAS was highest 
in patients with III and IV groups (up to 4.9 ± 0.2 mmol / l). 
Therefore, differentiated pathogenic treatment of multivariable anovulatory 
infertility with application of antiandrogenic therapy by Dexamethasone for 
adrenal genesis hyperandrogenism and Bromocriptine at hyperprolactinemia of 
non-cancerous growth genesis proceeds in the broken mechanisms of ovulation 
promotes efficiency of application of Clomiphene and leads to pregnancy in 
33.8% of patients. 
Our results are higher on efficiency, which over of other scientists in the 
undifferentiated treatment of anovulatory infertility, which testifies to the 
efficiency of the applied drug schemes. 
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With the uselessness of this treatment tactics and preservation of polycystic 
ovaries we recommend a surgical induction of ovulation by laparoscopic partial 
ovarian destruction, because such method improves the efficiency of complex 
infertility treatment to 40%. 
Conclusions. 
1. Multifactorial infertility as a combination of hyperprolactinemia and 
PCOS occurs in every third women with impaired fertility function. 
2. Differentiated application of conservative medical therapy allows to attain 
the effect of proceeding in a fertile function in 33, 8% of patients. 
3. It is concluded that surgical induction of ovulation by ovarian 
laparoscopic partial degradation is an option in the management of female 
infertility associated with PCOS, especially as a second-line treatment 
after the failure of clomiphene citrate treatment, enhancing the efficiency 
of complex infertility treatment to 40%. 
4. It is feasible to develop an algorithm differentiated use of infertility 
treatments in women with PCOS and hyperprolactinemia. 
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